February 2025 in “Diagnostics” Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.
The robotic system for hair restoration surgery works well, giving similar results to manual techniques after 9 months.
December 2022 in “Curēus” Genetic testing confirmed a young girl has Atrichia with Papular Lesions due to mutations in the hairless gene.
July 2024 in “Journal of Investigative Dermatology” December 2024 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Deucravacitinib helped a man regrow hair significantly.
110 citations
,
February 2024 in “Journal of Chemical Information and Modeling” PandaOmics uses AI to find new disease treatment targets and biomarkers.
SL-HyDE improves medical information retrieval accuracy without needing labeled data.
7 citations
,
March 2018 in “Development” New imaging technologies help us see how stem cells work in living animals.
July 2024 in “Journal of Investigative Dermatology” Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.
March 2018 in “Surgical and Radiologic Anatomy” High-resolution imaging is crucial for diagnosing and planning treatments in clinical anatomy and aging.
9 citations
,
May 2025 in “Stem Cell Research & Therapy” Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.
32 citations
,
December 2017 in “Journal of the American Academy of Dermatology” Alopecia areata patients often have low vitamin D levels.
June 2023 in “Skin Research and Technology” High-resolution MRI can distinguish between tertiary androgenetic alopecia and severe alopecia areata by measuring scalp and tissue thickness and hair follicle depth.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The study introduces ScalpViT, a novel hybrid deep learning model designed to accurately diagnose visually similar scalp diseases, such as Psoriasis, Seborrheic Dermatitis, Tinea Capitis, Alopecia Areata, Folliculitis, and Eczema. These conditions often share overlapping visual features, making diagnosis challenging. ScalpViT combines a Vision Transformer (ViT) and a Convolutional Neural Network (CNN) with a cross-attention fusion module to capture both global spatial patterns and local texture details. Trained on a dataset of approximately 7,000 images, ScalpViT achieved a 94.3% accuracy, outperforming other models like ResNet-50 and EfficientNet-B3. The model also provides visual explainability through GradCAM and Attention Rollout, enhancing its clinical applicability, especially in resource-limited settings.
7 citations
,
January 2018 in “Neurodegenerative Diseases” Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.
August 2024 in “Journal of Vaccines Immunology and Immunopathology” A COVID-19 vaccine may trigger severe hair loss in rare cases.
March 2025 in “Biomedical & Pharmacology Journal” Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.
June 2024 in “JEADV Clinical Practice” Severe alopecia areata patients have a low chance of spontaneous hair regrowth.
109 citations
,
January 2011 in “Frontiers in Systems Neuroscience” Choosing the right model order in brain connectivity analysis can affect the detection of differences between healthy individuals and those with seasonal affective disorder.
May 2026 in “Jurnal Sehat Indonesia (JUSINDO)” Low vitamin D levels may worsen or cause alopecia areata.
20 citations
,
June 2010 in “Genes and Immunity” Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.
18 citations
,
April 2013 in “PLOS ONE” Mice with autoimmune hair loss showed signs of heart problems.
7 citations
,
July 1979 in “Archives of Dermatology” Patients with renal disease should be cautious with vitamin A supplements due to risk of toxicity.
June 2023 in “International journal of pharmaceutical quality assurance” Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.
June 2007 in “Taiwan Journal of Ophthalmology” Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.
143 citations
,
January 2004 in “Journal of Investigative Dermatology Symposium Proceedings” Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.
January 1995 in “Adolescent and pediatric gynecology” Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.
December 2024 in “Dermatological Reviews” New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.
August 2025 in “Galen Medical Journal” Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.
July 2026 in “The Journal of Immunology” This study investigates the role of CD8 T cell-derived molecules in Alopecia Areata (AA) using a C3H/HeJ murine model. The research demonstrates that interferon gamma (IFNg) is a crucial effector molecule for CD8 T cells to induce AA, as IFNg-deficient CD8 T cells failed to transfer the disease. In contrast, perforin was found to be dispensable, as perforin-deficient CD8 T cells could still transfer the disease. Additionally, mice lacking the IFNg receptor (IFNgrKO) were unable to develop AA, highlighting the importance of IFNg sensing by the immune system in disease pathogenesis. These findings suggest that targeting IFNg pathways could be a potential therapeutic strategy for AA.